3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Status
Unknown
2
Recruiting
2
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Conditions
Seminoma
2
Ovarian Neoplasms
2
Neoplasms, Germ Cell and Embryonal
2
Hodgkin Disease
2
Vulvar Neoplasms
1
Testicular Neoplasms
1
Teratoma
1
Skin Neoplasms
1
Ovarian Germ Cell Cancer
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Gynecological Cancers
1
Endodermal Sinus Tumor
1
Carcinoma, Embryonal
1
Interventions
Bevacizumab
40
Paclitaxel
35
Carboplatin
28
pembrolizumab
21
Cyclophosphamide
15
Specimen Handling
14
Cisplatin
13
olaparib
11
Blood Specimen Collection
11
niraparib
10
fludarabine
10
Magnetic Resonance Spectroscopy
9
Drug Therapy
9
liposomal doxorubicin
8
Topotecan
8
Taxes
8
Gemcitabine
8
Biopsy
8
Fulvestrant
7
Doxorubicin
6
cemiplimab
5
abemaciclib
5
Surveys and Questionnaires
5
Standard of Care
5
Injections
5
Fluorouracil
5
Cytoreduction Surgical Procedures
5
trastuzumab deruxtecan
4
mirvetuximab soravtansine
4
aldesleukin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Ovarian Neoplasms
×
Bleomycin
×
Clear all
NCT02429687
2023-04-25
MOGCT-01
Shandong University
Phase 3
Recruiting
129 enrolled
NCT02429700
2023-04-25
SCST-01
Shandong University
Phase 3
Recruiting
132 enrolled